BTIG acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics Reports Improved Financials Amid Challenges
- Outlook Therapeutics announces common stock, warrants offering
- Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
- Biotech Alert: Searches spiking for these stocks today
- Outlook Therapeutics reports Q2 EPS (40c), consensus (55c)